iBio, Inc. (IBIO) — Institutional Holders, Q2 2026

55 institutional investment managers reported a IBIO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $60.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

IBIO in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

16

Added to

21

Trimmed

9

Sold out

12

Biggest buyers

  1. Cormorant Asset ManagementNew · +3,570,000 sh+$6.2M
  2. SILVERARC CAPITAL MANAGEMENTAdded · +3,294,490 sh+$5.8M
  3. Vestal Point CapitalNew · +2,600,000 sh+$4.5M
  4. Ensign Peak AdvisorsNew · +1,832,457 sh+$3.2M
  5. Woodline PartnersNew · +1,776,547 sh+$3.1M

Biggest sellers

  1. EcoR1 CapitalSold out · -1,583,000 sh-$2.8M
  2. Logos Global ManagementSold out · -1,300,000 sh-$2.3M
  3. SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -412,725 sh-$722.3K
  4. ADAR1 Capital ManagementTrimmed · -94,347 sh-$165.1K
  5. Lynx1 Capital ManagementSold out · -68,076 sh-$119.1K

IBIO 13F holders ranked 1–55 of 55

Institutional investors reporting a position in iBio, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Affinity Asset Advisors#1 · 4,007,881 sh$7.0M+29.0%
Cormorant Asset Management#2 · 3,570,000 sh$6.2MNew
SILVERARC CAPITAL MANAGEMENT#3 · 3,520,490 sh$6.2M+1457.7%
Vestal Point Capital#4 · 2,600,000 sh$4.5MNew
VANGUARD CAPITAL MANAGEMENT#5 · 2,098,151 sh$3.7M+92.8%
Frazier Life Sciences Management, L.P.#6 · 1,953,467 sh$3.4M0.0%
Ensign Peak Advisors#7 · 1,832,457 sh$3.2MNew
Woodline Partners#8 · 1,776,547 sh$3.1MNew
MILLENNIUM MANAGEMENT#9 · 1,651,473 sh$2.9M+6.6%
CITADEL ADVISORS#10 · 1,384,029 sh$2.4M+44.7%
BALYASNY ASSET MANAGEMENT L.P.#11 · 1,170,893 sh$2.0M+15.8%
BANK OF AMERICA#12 · 1,121,492 sh$2.0M+286.2%
Ikarian Capital#13 · 957,062 sh$1.7M0.0%
Sio Capital Management#14 · 904,268 sh$1.6M0.0%
MARSHALL WACE, LLP#15 · 904,132 sh$1.6M+45.7%
GEODE CAPITAL MANAGEMENT#16 · 500,816 sh$876.6K+29.2%
Walleye Capital#17 · 500,375 sh$875.7K+28.8%
Squarepoint Ops#18 · 498,872 sh$873.0KNew
NOESIS CAPITAL MANGEMENT#19 · 405,000 sh$708.8K+30.0%
TWO SIGMA INVESTMENTS#20 · 400,667 sh$701.2K-2.0%
Ally Bridge Group (NY)#21 · 390,147 sh$682.8KNew
ADAR1 Capital Management#22 · 375,531 sh$657.2K-20.1%
Verdad Advisers#23 · 298,927 sh$523.1K+430.8%
VANGUARD FIDUCIARY#24 · 286,875 sh$502.0K+39.9%
BOOTHBAY FUND MANAGEMENT#25 · 254,412 sh$445.2K0.0%
BlackRock#26 · 242,016 sh$423.5K+84.4%
RENAISSANCE TECHNOLOGIES#27 · 202,847 sh$355.0KNew
GOLDMAN SACHS GROUP#28 · 200,455 sh$350.8K+0.1%
STATE STREET#29 · 170,799 sh$298.9K+21.0%
DAFNA Capital Management#30 · 170,053 sh$297.6K-12.2%
NORTHERN#31 · 111,319 sh$194.8K+44.0%
Atom Investors#32 · 101,557 sh$177.7KNew
XTX Topco Ltd#33 · 57,842 sh$101.2K-7.4%
Headlands Technologies#34 · 47,413 sh$83.0K+333.0%
TWO SIGMA SECURITIES#35 · 16,151 sh$28.3KNew
Innovative Asset Advisors Group#36 · 15,000 sh$26.3KNew
Spark Investment Management#37 · 13,500 sh$23.6KNew
Bank of New York Mellon#38 · 10,637 sh$18.6KNew
JPMORGAN CHASE#39 · 5,897 sh$10.2KNew
Vanguard Global Advisers#40 · 5,460 sh$9.6K0.0%
BARCLAYS PLC#41 · 3,255 sh$5.7KNew
UBS Group AG#42 · 501 sh$877.00-76.9%
FMR#43 · 433 sh$757.00New
Fortitude Family Office#44 · 431 sh$754.00-32.4%
OSAIC#45 · 380 sh$665.00-34.9%
WELLS FARGO & COMPANY#46 · 101 sh$177.00+10000.0%
SHP Wealth Management#47 · 60 sh$105.000.0%
SBI Securities , Ltd.#48 · 42 sh$74.00+90.9%
SOA Wealth Advisors#49 · 13 sh$23.000.0%
MORGAN STANLEY#50 · 10 sh$18.00-100.0%
Caitong International Asset Management , Ltd#51 · 9 sh$16.00+350.0%
Activest Wealth Management#52 · 4 sh$7.000.0%
BNP PARIBAS FINANCIAL MARKETS#53 · 2 sh$4.00-60.0%
Financial Gravity Companies, (FGCO)#54 · 2 sh$4.00—
Rockefeller Capital Management L.P.#55 · 1 sh$2.00New

Funds that sold out of IBIO in Q2 2026 (12)

Held IBIO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held IBIO in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
EcoR1 Capital1,583,000 sh$3.0M
Logos Global Management1,300,000 sh$2.5M
SUSQUEHANNA INTERNATIONAL GROUP, LLP412,725 sh$784.2K
Lynx1 Capital Management68,076 sh$129.3K
PFG Investments20,000 sh$38.0K
Vanguard Personalized Indexing Management12,180 sh$23.1K
Scientech Research11,402 sh$21.7K
Virtu Financial10,822 sh$21.0K
ROYAL BANK OF CANADA3,891 sh$7.0K
CITIGROUP1,373 sh$2.6K
Hillsdale Investment Management32 sh$61.00
Steward Partners Investment Advisory1 sh$2.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.